John Slattery, CEO of BioROSA Technologies, shares the story of why he is developing a highly accurate blood test that will detect Autism Spectrum disorder in children as young as 18 months.Listen to John’s inspiring story of how finding a sense of purpose built the foundations, vision and passion that led to him creating a business that is positively impacting a large amount of change in the ASD population. Over 30M children and over 100M+ people around the world are suffering from Autism Spectrum Disorders (ASD).  Back in the 70s and 80s, it was believed that autism affected 1 in 10,000 children in the US. Now the current estimate is 1 in 54 children in the US. A snippet of what John shares in this episode: “You can’t help but not want to do something once you’ve been exposed to this community”“I’m very much a fighter and survivor”“Covid exposed all the holes in the current medical system”“You have to have that introspective look and be able to listen to others”“Active listening without any doing is empty”“The future looks unbelievably bright not only for early detection but for early intervention”Click here to reach out to Peter Rabey direct Like this show? Please leave us a review. Every review helps.